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Abstract
Purpose: Disseminated malignancies are a diagnostic and therapeutic challenge that is often encountered in radiology. 
Finding the primary tumour is crucial for planning proper surgical and oncological treatment. Computed tomogra-
phy (CT) of the thorax and abdomen is typically the initial examination. However, abdominal magnetic resonance 
imaging (MRI) or positron emission tomography (PET/CT) or PET/MRI are often subsequently performed. Histo-
pathological examination of metastatic tumours is performed as well, followed by immunohistochemistry. The aim 
of the report was to present diagnostic workup in a rare case of skin metastases.
Case report: A 72-year-old patient was admitted to a dermatology ward because of skin lesions – violaceous nodules 
localised on the hair-covered skin of the head. On abdominal CT, a generalised neoplastic process with metastases in 
the liver, pancreas, adrenal glands, lymph nodes, bones, thoracic wall, and a suspected metastasis in the right breast 
was revealed. Histopathology of the skin nodules confirmed a neuroendocrine tumour. Metastases of a pancreatic 
neuroendocrine tumour or small-cell lung cancer were suspected on immunohistochemistry. The patient died before 
we were able to localise the primary source of the tumour and provide treatment.
Conclusions: Skin metastases are relatively rare, aggravate the prognosis, and usually indicate spread of the neoplastic 
process in the internal organs. It is not always possible to localise the primary tumour using radiological imaging. In 
such cases, co-operation with the pathologist is crucial as are the results of histopathological and immunohistochemical 
examinations.
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Introduction
Disseminated malignancies are a diagnostic and therapeu-
tic challenge that is often encountered in radiology. The lo-
calisation of the primary tumour is crucial for planning ap-
propriate surgical and oncological treatment. Sometimes, 
standard imaging techniques cannot reveal the primary 
tumour. In such cases, co-operation with the pathologist is 
needed in order establish a diagnosis based on histopatho-
logical and immunohistochemical examinations.
Case report
A 72-year-old female patient, diagnosed with Binswan-
ger’s disease, with a history of tuberculosis, after surgery 
due to a compression fracture of the L1 vertebra was ad-
mitted to a dermatology ward because of skin lesions – 
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violaceous noduleslocalised on the hair-covered skin 
of the head, in the left external acoustic meatus, on the 
back, and in the left groin (Figure 1). The first lesions ap-
peared one month before admission, and had been rapid-
ly progressing, engulfing the abovementioned body parts. 
Laboratory studies showed macrocytic anaemia, decreas-
ed activated partial thromboplastin time (APTT), a de-
creased level of folic acid, an increased level of D-dimer, 
and a slightly increased level of carcinoembryonic anti-
gen (CEA). Symptomatic treatment was started – packed 
red blood cells were transfused and ionic balance was 
restored. Contrast-enhanced abdominal computed to-
mography (CT) revealed an enlargement of the head of 
pancreas and focal lesions with hypodense areas corre-
sponding to necrotic changes. Evaluation of focal lesions 
in the liver and adrenal glands was impeded by artefacts 
resulting from L1 vertebroplasty. Two metastatic lesions 
were found in the liver, and similar lesions were also ob-
served in both adrenal glands and in the wall of the tho-
rax, destructing the ribs. Suspected metastatic lesions were 
found in the right breast (Figure 2). The clinical picture 
and imaging studies indicated a disseminated malignan-
cy. Histopathology of the skin nodules confirmed a neu-
roendocrine tumour (Figure 3A and 3B). Metastases of 
a pancreatic neuroendocrine tumour or small-cell lung 
cancer were suspected based on a positive cytokeratin 
reaction (CK Pan+, CK18+, CK19+, synaptophysin+) on 
immunohistochemistry (Figure 3C and 3D). Because of 
a poor general condition, the patient was transferred to an 
endocrinology ward, where she died before determining 
the primary tumour and did not receive treatment.
Discussion
Skin metastases are an important therapeutic issue although 
their occurrence is rare. Skin metastases most commonly 
occur in the course of breast cancer in women and lung 
cancer in men. They usually form violaceous nodules and 
Figure 1. Skin metastasis. Skin of the head (A, B). Left external acoustic meatus (C)
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Figure 2. Disseminated malignancy with a prob-
able origin in the pancreas. Contrast-enhanced 
computed tomography in the arterial phase 
shows a soft tissue mass with rib destruction (A), 
an enhancing mass in the right breast (B), bilat-
eral adrenal metastases (C), multiple osteolytic 
metastases (D),and pancreatic head tumour (E)
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tumours, sometimes decaying. These changes can most of-
ten be found on the skin of the head, torso, and less com-
monly of the limbs. Skin metastases appear in different lo-
cations, sometimes distant from the primary focus, and they 
usually do not cause pain [1]. Their appearance is usually 
a sign of disease progression, and indicates poor prognosis 
[2]. Metastases can also be a sign of tumour recurrence after 
successful treatment or be the first symptom of malignan-
cy. Merkel-cell carcinoma, hemangioma, angiogranuloma, 
keloids, primary skin cancers including squamous cell car-
cinoma (SCC), melanoma, and cancers of the sweat glands 
or other appendages are included most commonly in the 
differential diagnosis. The characteristic clinical picture of 
skin lesions in the discussed patient suggested metastases 
and thus malignancy as the primary disease.
In our patient, the source of skin metastases was a neu-
roendocrine tumour (NET), which is exceptionally rare. 
Neuroendocrine tumours are a group of heterogeneous 
tumours which originate from cells of the neuroendo-
crine system, scattered within different organs, and usu-
ally form in the lungs, small intestine, and rectum [3,4]. 
These tumours are diagnosed in 2.5-5 per 100,000 people 
per year, women and men are equally affected, usually in 
their sixties [4,5]. It is reported that 9% to 19% of patients 
with neuroendocrine tumours are also diagnosed with dis-
seminated metastases of an unknown primary source [6].
Tumours of unknown primary location constitute 
a very heterogeneous group of diseases. In around 50% 
of cases, numerous metastases are found at diagnosis; 
from the most to the least common: in the lymph nodes, 
lungs, bones, liver, pleural cavity, and brain [7]. Location 
of the primary tumour is usually determined by means of 
medical imaging. Typically, CT of the thorax or the abdo-
men is performed, and sometimes head CT is necessary. 
Although CT exposes patients to negative effects of ion-
ising radiation, it is easy, fast, relatively cheap, and recom-
mended by most oncological guidelines for determining 
the stage of disease. The diagnostic examination tools that 
are also used to determine the primary focus are magnetic 
resonance imaging (MRI) and scintigraphic tests, such as 
somatostatin receptor scintigraphy (SRS) [8]. However, 
MRI is expensive and not easily available in some facili-
ties. On the other hand, the effectiveness of SRS examina-
tion used to locate the primary focus of a small intestine 
neuroendocrine tumour is estimated at only 37% [9].
Much attention has focused on the diagnosis and 
treatment of pancreatic endocrine tumours (PETs). On 
abdominal CT, these tumours can be seen as distinctive 
Figure 3. Histopathological examination, H and E. Cells are small, round, with the same appearance and rim of narrow cytoplasm. Round nuclei, “salt pepper” 
chromatin appearance with numerous nucleoli. Several cell division figures, including pathological mitosis. ×40 (A). ×100 (B). Immunohistochemistry 
×200. CK Pan + (C). Synaptophysin + (D)
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solid masses which tend to model surrounding structures. 
They are characterised by intense contrast enhancement 
in both the arterial and the venous phase, which is due 
to a large net of capillary vessels [10]. Smaller changes 
are usually more homogeneous, and bigger tumours are 
commonly characterised by heterogeneous enhancement 
with areas of cystic degeneration, necrosis, fibrosis, and 
calcification [11]. Sensitivity and specificity are high for 
CT- and MRI-assisted localisation of pancreatic neuroen-
docrine tumours, but detectability of these tumours by 
means of these techniques is much lower [12].
Neuroendocrine tumours can also be imaged with 
nuclear medicine techniques that utilise two types of ra-
diolabelling, namely, receptor expression and metabol-
ic activity of the tumour [13]. In 2017, a study showed 
that 68Ga-DOTA-TOC PET/CT using the 68Ga-DOTA- 
D-Phe1-Try3-Octreotide label was helpful in localising pri-
mary neuroendocrine tumours in 37% of patients with 
disseminated neoplastic disease in whom conventional 
imaging techniques, such as CT or MRI, could not con-
tribute to final diagnosis [8]. This examination is particu-
larly useful in patients with an unknown primary focus 
in low-grade and intermediate-grade metastases. Our pa-
tient was diagnosed with high-grade metastases, thus an 
examination using 68Ga-DOTA-D-Phe1-Try3-Octreotide 
could not have been sufficient to establish a final diagno-
sis. Another study, performed in 2016, compared the ef-
fectiveness of PET/CT and PET/MRI in localising prima-
ry tumours in patients with metastatic neoplastic disease 
[14]. It showed that both hybrid imaging techniques have 
comparable diagnostic capabilities in diagnosing primary 
cancers and metastases, with PET/MRI providing the best 
results in the neck and PET/CT in the lungs. As ionising 
radiation doses used in PET/MRI are much lower, it can 
be an effective alternative to PET/CT, especially for treat-
ment monitoring that requires repeat imaging [14].
Conventional ultrasound imaging is typically used 
as a screening test, and is sometimes followed by CT or 
MRI. Ultrasound guidance can be helpful in performing 
biopsy of lesions or metastatic lymph nodes as it can de-
termine the place of specimen collection. Contrast-en-
hanced ultrasonography (CEUS) is a promising modality 
which uses intravenous contrasting media and measures 
contrast enhancement on ultrasound images [15]. In CT, 
iodinated contrast agents are typically used, which can 
lead to contrast-induced nephropathy (CIN), especially 
in elderly patients with chronic kidney disease or diabetes 
[16]. CEUS uses intravenous microbubbles, which allows 
to visualize local tissue vascularization and perfusion and 
is not associated with CIN [17].
Neuroendocrine tumours detected on imaging should 
be differentiated from other vessel-rich lesions, e.g. me-
tastases, neurogenic tumours, vessel malformations, or 
primary exocrine tumours [18].
Radiological imaging is often unspecific, and neoplas-
tic disease can be disseminated to such an extent that it is 
impossible to determine the primary focus by CT, MRI, 
SRS, or PET. In some cases, only co-operation between 
clinicians, radiologists, and pathologists can lead to final 
diagnosis and localisation of the primary tumour. The 
results of the histopathological and immunochemical ex-
aminations in our patient indicated a pancreatic tumour 
or small-cell lung cancer. In order to confirm the primary 
pancreatic tumour, additional immunohistochemical as-
says would have been necessary, namely: chromogranin 
A, Ki67/MIB1, hormone expression assay, and assessments 
determining the stage of expression and type of somatosta-
tin receptors. In order to confirm a primary lung tumour, 
a cytological sputum examination, bronchial swab, and 
bronchoalveolar lavage would have been necessary. On 
immunohistochemistry, a positive result for TTF-1 would 
have confirmed primary lung cancer. These examinations 
were not conducted because of the patient’s death. How-
ever, determining the source of a neoplastic disease in pa-
tients with neuroendocrine tumours seems to be crucial 
as even in patients with NET with non-resectable liver 
metastases localising the primary focus is beneficial [19].
Conclusions
Skin metastases are relatively rare, aggravate the prognosis, 
and usually indicate spread of the malignant process to the 
internal organs. Unspecific clinical picture can be diagnos-
tically challenging. Imaging studies do not always indicate 
the localization of the primary tumour. How ever, they help 
determine the clinical advancement of the neoplastic dis-
ease. The location of the primary tumour should usually be 
confirmed by histopathology and immunohistochemistry.
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